Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: Analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy-Reference-Cited by-同舟云学术

Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: Analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy

Published:2003-11 Issue:3 Volume:57 Page:739-747
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zagars Gunar K,Ballo Matthew T,Pisters Peter W.T,Pollock Raphael E,Patel Shreyaskumar R,Benjamin Robert S

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference30 articles.

1. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence;Ramanathan;Ann Surg Oncol,2001

2. The management of locally recurrent soft-tissue sarcoma;Giuliano;Ann Surg,1982

3. Local recurrence and survival in soft tissue sarcomas;Karakousis;Ann Surg Oncol,1996

4. Long-term salvageability for patients with locally recurrent soft-tissue sarcomas;Singer;Arch Surg,1992

5. Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients;Roth;Cancer,1985

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinical tool to predict overall survival of elderly patients with soft tissue sarcoma after surgical resection;Scientific Reports;2024-07-02

2. Ultra-low-dose computed tomography and chest X-ray in follow-up of high-grade soft tissue sarcoma—a prospective comparative study;Scientific Reports;2024-03-26

3. (Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient’s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study);BMJ Open;2023-11

4. Diagnostic Superiority of Dual-Time Point [18F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors;Diagnostics;2023-10-13

5. CivaSheet® use for soft tissue sarcoma: A single institution experience;Brachytherapy;2023-09